Request Demo
Last update 27 Dec 2024
Pneumococcal polysaccharide vaccine 23-valent (Beijing Luzhu Biopharma)
Last update 27 Dec 2024
Overview
Basic Info
Drug Type Prophylactic vaccine, Multivalent vaccine |
Synonyms 优威克 |
Target- |
Mechanism Immunostimulants |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhaseApproved |
First Approval Date CN (29 Aug 2023), |
Regulation- |
Login to view timeline
Related
7
Clinical Trials associated with Pneumococcal polysaccharide vaccine 23-valent (Beijing Luzhu Biopharma)CTR20243701
在大规模人群中接种23价肺炎球菌多糖疫苗的安全性观察研究
[Translation] An observational study on the safety of 23-valent pneumococcal polysaccharide vaccine in a large population
NCT06703203
A Single-center, Randomized, Double-blind, Active-controlled Phase I/II Clinical Trial to Evaluate the Safety and Immunogenicity of 26-valent Pneumococcal Conjugate Vaccine in People Aged 2 Months and Older
CTR20233877
单中心、开放评价23价肺炎球菌多糖疫苗Ⅲ期临床50岁以上人群免疫持久性的临床试验
[Translation] A single-center, open-label clinical trial evaluating the durability of immunity of a 23-valent pneumococcal polysaccharide vaccine in a phase III trial in people over 50 years old
100 Clinical Results associated with Pneumococcal polysaccharide vaccine 23-valent (Beijing Luzhu Biopharma)
Login to view more data
100 Translational Medicine associated with Pneumococcal polysaccharide vaccine 23-valent (Beijing Luzhu Biopharma)
Login to view more data
100 Patents (Medical) associated with Pneumococcal polysaccharide vaccine 23-valent (Beijing Luzhu Biopharma)
Login to view more data
100 Deals associated with Pneumococcal polysaccharide vaccine 23-valent (Beijing Luzhu Biopharma)
Login to view more data
R&D Status
Approved
10 top approved records. to view more data
Login
| Indication | Country/Location | Organization | Date |
|---|---|---|---|
| Pneumococcal Infections | CN | 29 Aug 2023 |
Developing
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Bacteremia | Phase 3 | CN | 10 Mar 2018 | |
| Meningitis | Phase 3 | CN | 10 Mar 2018 | |
| Otitis Media | Phase 3 | CN | 10 Mar 2018 | |
| Pneumonia, Pneumococcal | Phase 3 | CN | 12 Jan 2018 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
Chat with Hiro
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free